Analytica Share Price and Company Fundamentals
Last traded: Last Thursday at 12:00 AM
Analytica Limited designs, develops, and supplies medical devices in Australia, China, and the Middle East. The company's lead product is PeriCoach system, an e-health treatment system for women used in treatment of stress urinary incontinence. Its PeriCoach comprises a device, Web portal, and smartphone app for evaluating activity in pelvic floor muscles. The company also provides Autostart Burette Infusion System for monitoring and refilling of burettes in intravenous fluid infusion. Analytica Limited was incorporated in 1985 and is based in Brisbane, Australia.
|Primary activities||Analytica is a medical device commercialisation company with focus on late-stage, low regulatory risk products. Products include the PeriCoach (R) system for treatment of female urinary incontinence and other pelvic floor health conditions, .|
|Industry / Sector||Medical Devices / Healthcare|
|Mailing address||320 Adelaide Street Brisbane QLD 4000 Australia|
|Phone / Fax||61 7 3278 1950 /|
|Share registry||LINK MARKET SERVICES LIMITED|
Analytica does not pay dividends.
As of Sep 2021, following are the company executives and directors listed on Analytica.
|Dr. Michael Monsour||Exec. Chairman|
|Mr. Geoff Daly BE (Hons, Mech, UQ), MBA (Exec, AGSM), MIEAust CPE||Chief Exec. Officer|
|Mr. Ross Mangelsdorf B.Bus, FCA, CTA, FTIA, MAICD||CFO & Exec. Director|
|Ms. Chelsea Cornelius||Chief Operating Officer|
|Ms. Megan Henken||VP of Global Marketing|
|Mr. Bryan Dulhunty ACA, BEc, C.A.||Company Sec.||19.07k|
Profitability and management effectiveness
Return on assets
Return on equity
Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.
The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.
Valuation and Trading Info
The market capitalization of Analytica is 9.23M and its enterprise value is 7.34M. The enterprise value to revenue ratio of ALT is 9.15.
The ALT's stocks Beta value is 0.54 making it 46% less volatile compared to ASX market index. Technology stocks and small caps tend to have higher betas than the market benchmark. This indicates that adding the stock to a portfolio will increase the portfolio’s risk, but also increase its expected return. On the other hand utility stocks often have low betas because they tend to move more slowly than market averages.
Companies similar to Analytica (ALT)
- Ansell (ANN)
- Cochlear (COH)
- Estia Health (EHE)
- Fisher & Paykel Healthcare Corporation (FPH)
- Healius (HLS)
- Nanosonics (NAN)
- Polynovo (PNV)
- Pro Medicus (PME)
- Ramsay Health Care (RHC)
- Resmed Inc (RMD)
- Sonic Healthcare (SHL)
Analytica (ASX:ALT) Frequently Asked Questions
1. What is Analytica's Stock Symbol?
Analytica trades on ASX under the ticker symbol "ALT".
2. What is Analytica's stock price today?
One share of ALT stock can currently be purchased for approximately $0.002.
3. How can I contact Analytica?
Analytica's mailing address is 320 Adelaide Street Brisbane QLD 4000 Australia. The company can be reached via phone at 61 7 3278 1950.
4. What is Analytica's official website?
The official website of Analytica is http://www.analyticamedical.com.
5. Which share registry manages Analytica's stock?
Analytica's stock is managed by LINK MARKET SERVICES LIMITED.